New Delhi: Cognizant Technology Solutions has accused Infosys of stealing the trade secrets of its healthcare software, TriZetto, in a recent filing with a US court, calling it a case of being “caught red-handed,” according to a Mint report. This follows a counterclaim by Infosys over a month ago, in which it accused Cognizant and its CEO, Ravi Kumar, of anti-competitive practices and misusing confidential information to hinder the growth of Infosys’ healthcare platform, Infosys Helix.
Cognizant’s court filing, submitted on February 7, 2025, claims that Infosys misappropriated TriZetto’s trade secrets, which Infosys had previously accessed under non-disclosure and access agreements (NDAAs). The filing, a 22-page court reply, states that Infosys had been caught red-handed misusing TriZetto’s proprietary information.
Cognizant’s subsidiary, Cognizant TriZetto, filed a lawsuit in a Texas federal court, accusing Infosys of stealing trade secrets related to its healthcare insurance software, including TriZetto’s Facets and QNXT platforms, used by healthcare insurance companies to automate administrative processes. Cognizant alleges that Infosys misused TriZetto’s software to create “Test Cases for Facets,” which improperly repackaged TriZetto’s data into an Infosys product.
In its response, Cognizant further claimed that Infosys had refused to allow an audit of its use of TriZetto’s information, which could have provided evidence of the alleged wrongdoing. “When confronted, Infosys obfuscated to the maximum extent, asking TriZetto to simply trust, without evidence, that no misconduct had occurred,” Cognizant said. When TriZetto insisted on an audit, as allowed under the NDAAs, Infosys reportedly refused to comply.
Cognizant is now requesting the court to compel Infosys to produce all relevant documents related to the matter.